Concerted clearance of immune complexes bound to the human erythrocyte complement receptor: Development of a heterologous mouse model

Journal of Immunological Methods

Volumn 270, Issue 2, 2002, Pages 183-197

  Henderson, Andrea L ^a   Lindorfer, Margaret A ^a   Kennedy, Adam D ^a   Foley, Patricia L ^a   Taylor, Ronald P ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Complement; In vivo animal models; Monocytes macrophages; Phagocytosis

Indexed keywords

COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C3B; COMPLEMENT RECEPTOR; DOUBLE STRANDED DNA; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY; POLYMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BINDING KINETICS; BIOLOGICAL MODEL; CONTROLLED STUDY; CROSS LINKING; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; KUPFFER CELL; LIVER LEVEL; MOLECULAR STABILITY; MOUSE; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIGEN-ANTIBODY COMPLEX; ERYTHROCYTES; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN G; KUPFFER CELLS; LIVER; MICE; MICE, INBRED A; MICROSCOPY, FLUORESCENCE; MODELS, ANIMAL; RADIOIMMUNOASSAY; RECEPTORS, COMPLEMENT;

ANIMALIA; MURINAE; PRIMATES;

EID: 0037114284     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(02)00296-X     Document Type: Article

References (40)

1. Cornacoff J.B., Hebert L.A., Smead W.L., Van Aman M.E., Birmingham D.J., Waxman F.J. Primate erythrocyte-immune complex-clearing mechanism. J. Clin. Invest. 71:1983;236.
2. Cosio F.G., Xiao-Ping S., Birmingham D.J., Van Aman M., Hebert L.A. Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates. J. Immunol. 145:1990;4198.
3. Craig M.L., Bankovich A.J., McElhenney J., Taylor R.P. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism. Arthritis Rheum. 43:2000;2265.
4. Cross A., Asher L., Seguin M., Yuan L., Kelly N., Hammack C., Sadoff J. The importance of a LPS-initiated, cytokine-mediated host defense mechanism in mice against extraintestinally invasive E. coli. J. Clin. Invest. 96:1995;676.
5. Davies K.A., Hird V., Stewart S., Sivolapenko G.B., Jose P., Epenetos A.A., Walport M.J. A study of in vivo immune complex formation and clearance in man. J. Immunol. 144:1990;4613.
6. Davies K.A., Chapman P.T., Norsworthy P.J., Jamar F., Athanassiou P., Keelan E.T.M., Harrison A.A., Binns R.M., Haskard D.O., Walport M.J. Clearance pathways of soluble immune complexes in the pig: insight into the adaptive nature of antigen clearance in humans. J. Immunol. 155:1995;5769.
7. Dijstelbloem H.M., van de Winkel J.G., Kallenberg C.G. Inflammation in autoimmunity: receptors for IgG revisited. Trends Immunol. 22:2001;510.
8. Edberg J.C., Wright E., Taylor R.P. Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells. J. Immunol. 139:1987;3739.
9. Edberg J.C., Tosic L., Wright E.L., Sutherland W.M., Taylor R.P. Quantitative analyses of the relationship between C3 consumption, C3b capture, and immune adherence of complement-fixing antibody/DNA immune complexes. J. Immunol. 141:1988;4258.
10. Emlen W., Pisetsky D.S., Taylor R.P. Antibodies to DNA. Arthritis Rheum. 29:1986;1417.
11. Ferguson P.J., Reist C.J., Martin E.N., Johnson C., Greene K.L., Kuhn S., Niebur J., Emlen W., Taylor R.P. Antigen-based heteropolymers: a potential therapy for binding and clearing autoantibodies via erythrocyte CR1. Arthritis Rheum. 38:1995;190.
12. Frei Y., Lambris J.D., Stockinger B. Generation of a monoclonal antibody to mouse C5: application in an ELISA assay for detection of anti-C5 antibodies. Mol. Cell. Probes. 1:1987;141.
13. Gavin A., Hulett M., Hogarth P.M. Molecular basis for the interaction of Fc receptors with immunoglobulins. van de Winkel J.G.J., Hogarth P.M. The Immunoglobulin Receptors and their Physiological and Pathological Roles in Immunity. 1998;11 Kluwer Academic Publishing, Dordrecht.
14. Gregory S.H., Wing E.J. Neutrophil-Kupffer-cell interaction in host defenses to systemic infections. Immunol. Today. 19:1998;507.
15. Huser H.-J. Atlas of Comparative Primate Hematology. 1970;Academic Press, New York.
16. Kammer G.M., Tsokos G.C. Lupus: Molecular and Cellular Pathogenesis. 1999;Humana Press, Totowa, NJ.
17. Kimberly R.P., Edberg J.C., Merriam L.T., Clarkson S.B., Unkeless J.C., Taylor R.P. In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees. J. Clin. Invest. 84:1989;962.
18. Kimberly R.P., Salmon J.E., Edberg J.C. Receptors for immunoglobulin G: molecular diversity and implications for disease. Arthritis Rheum. 38:1995;306.
19. Lindorfer M.A., Schuman T.A., Craig M.L., Martin E.N., Taylor R.P. A bispecific dsDNA×monoclonal antibody construct for clearance of anti-dsDNA IgG in systemic lupus erythematosus. J. Immunol. Methods. 248:2001;125.
20. Lindorfer M.A., Hahn C.S., Foley P.L., Taylor R.P. Heteropolymer-mediated clearance of immune complexes via erythrocyte CR1: mechanisms and applications. Immunol. Rev. 183:2001;10.
21. Lindorfer M.A., Nardin A., Foley P.L., Solga M.D., Bankovich A.J., Martin E.N., Henderson A.L., Price C.W., Gyimesi E., Wozencraft C.P., Goldberg J.B., Sutherland W.M., Taylor R.P. Targeting of Pseudomonas aeruginosa in the bloodstream with bispecific monoclonal antibodies. J. Immunol. 167:2001;2240.
22. Nardin A., Schlimgen R., Holers V.M., Taylor R.P. A prototype pathogen bound ex vivo to human erythrocyte complement receptor 1 via bispecific monoclonal antibody complexes is cleared to the liver in a mouse model. Eur. J. Immunol. 29:1999;1581.
23. Nelson R.A. The immune-adherence phenomenon. An immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis. Science. 118:1953;733.
24. Nelson R.A. The immune-adherence phenomenon. A hypothetical role of erythrocytes in defense against bacteria and viruses. Proc. R. Soc. Med. 49:1955;55.
25. O'Shea J.J., Brown E.J., Seligmann B.E., Metcalf J.A., Frank M.M., Gallin J.I. Evidence for the distinct intracellular pools of receptors for C3b and C3bi in human neutrophils. J. Immunol. 134:1985;2580.
26. Ravetch J.V., Clynes R.A. Divergent roles for Fc receptors and complement in vivo. Annu. Rev. Immunol. 16:1998;421.
27. Reinagel M.L., Taylor R.P. Transfer of immune complexes from erythrocyte CR1 to mouse macrophages. J. Immunol. 164:2000;1977.
28. Reinagel M.L., Gezen M., Ferguson P.J., Kuhn S., Martin E.N., Taylor R.P. The primate erythrocyte complement receptor (CR1) as a privileged site: binding of immunoglobulin G to erythrocyte CR1 does not target erythrocytes for phagocytosis. Blood. 89:1997;1068.
29. Reist C.J., Combs M.J., Croft B.Y., Taylor R.P. Antigens pre-bound to the primate erythrocyte complement receptor via cross-linked bispecific monoclonal antibody heteropolymers are rapidly cleared from the circulation. Eur. J. Immunol. 23:1993;3021.
30. Reist C.J., Liang H.Y., Denny D., Martin E.N., Scheld W.M., Taylor R.P. Cross-linked bispecific monoclonal antibody heteropolymers facilitate the clearance of human IgM from the circulation of squirrel monkeys. Eur. J. Immunol. 24:1994;2018.
31. Sluiter W., Oomens L.W., Brand A., van Furth R. Determination of blood volume in the mouse with 51chromium-labelled erythrocytes. J. Immunol. Methods. 73:1984;221.
32. Tan E.M., Schur P.H., Carr R.I., Kunkel H.G. Deoxyribonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J. Clin. Invest. 45:1966;1732.
33. Taylor R.P., Edberg J.C., Kujala G.A., Sloman A.J., Wilson C.C., Cronin M.E. The interaction of antibody/DNA immune complexes with complement. Influence of antibody class and DNA conformation. Arthritis Rheum. 30:1987;176.
34. Taylor R.P., Ferguson P.J., Martin E.N., Cooke J., Greene K.L., Grinspun K., Guttman M., Kuhn S. Immune complexes bound to the primate erythrocyte complement receptor (CR1) via anti-CR1 mAbs are cleared simultaneously with loss of CR1 in a concerted reaction in a rhesus monkey model. Clin. Immunol. Immunopathol. 82:1997;49.
35. Theofilopoulos A.N., Kono D.H. Murine lupus models: gene-specific and genome-wide studies. Lahita R.G. Systemic Lupus Erythematosus. 1999;145 Academic Press, San Diego.
36. Tsuji M., Ishihara C., Arai S., Hiratai R., Azuma I. Establishment of a SCID mouse model having circulating human red blood cells and a possible growth of Plasmodium falciparum in the mouse. Vaccine. 13:1995;1389.
37. Unkeless J.C. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150:1979;580.
38. Wallace P.K., Valone F.H., Fanger M.W. Myeloid cell-targeted cytotoxicity of tumor cells. Fanger M.W. Bispecific Antibodies. 1995;43 R.G. Landis, Austin.
39. Walport M., Ng Y.C., Lachmann P.J. Erythrocytes transfused into patients with SLE and haemolytic anaemia lose complement receptor type 1 from their cell surface. Clin. Exp. Immunol. 69:1987;501.
40. Winfield J.B., Faiferman I., Koffler D. Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. J. Clin. Invest. 59:1977;90.